Trial 0C-20-14


Tumor-agnostic precision immunooncology and somatic targeting rational for you (TAPISTRY) Phase II Platform trial

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Jorge Nieva, M.D.
Other Trial Staff:  Yan Ning, D.M., Cristina De Leon, Coordinator, Lorraine Martinez, Coordinator, Chi Nguyen, Coordinator, Leila Andres, Coordinator, Nicole Jensen, Coordinator, Mary Ordaz, D.M., Xiomara Menendez, Coordinator, Jessica Levano, Coordinator, Arthur Alvarez, Coordinator, Khatchik Karakozian, D.M., Niranjan Bhatt, D.M., Atessa Kiani, Coordinator, Negeen Izadian, Coordinator, Negeen Izadian, D.M., Cristina Lee, Coordinator, Diane Habib, Coordinator, Clara Karam, D.M., Stephanie Kim, Coordinator, Stephanie Kim, Coordinator, Maura Fernandez, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.